戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y in cells co-transfected with TRPC6 and AVP V1 receptor.
2  vasopressin neurones co-express vasopressin V1 receptors.
3 ephrine, vasopressin, and F-180, a selective V1 receptor agonist, were measured at 24 hrs.
4 he nature and expression of both vasopressin V1 receptors and human VACM are apparently unaffected by
5 the cells co-transfected with TRPC6-EGFP and V1 receptor, and this response was inhibited by catalase
6 m (5 mg/kg) or an arginine vasopressin (AVP) V1 receptor antagonist (AVPX, 10 microgram/kg).
7 al olfactory contextual cues in males, and a V1 receptor antagonist stimulated such responses, at lea
8 cking agent, but not an arginine vasopressin V1 receptor antagonist, lowered blood pressure.
9 i.v. treatment with either phentolamine or a V1-receptor antagonist dissolved in saline.
10 ment with phentolamine or a vasopressinergic V1-receptor antagonist on the fetal cardiovascular respo
11                                            A V1-receptor antagonist produced a femoral vasodilatation
12                                            A V1-receptor antagonist shifted the effects of vasopressi
13 analogue that acts, via vascular vasopressin V1 receptors, as a systemic vasoconstrictor.
14      No differences in the sequences for the V1 receptors between classical and variant SCCL were fou

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。